Immune responses to TG6002 infusion via the hepatic artery
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
mRNAseq to investigate the immunological effects of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine
应用场景：
创建时间：
2024-11-29
相关数据集
North America Oncolytic Virus Cancer Immunotherapy Market
The North America Oncolytic Virus Cancer Immunotherapy report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights i
IMR REPORTS40
Data Sheet 1_Overcoming immune resistance in advanced esophageal squamous cell carcinoma with recombinant human adenovirus type 5 by impacting the immune microenvironment: a case report.pdf
Advanced esophageal squamous cell carcinoma (ESCC) has a poor prognosis. Chemotherapy combined with immune checkpoint inhibitors is a feasible treatment, but effective treatment modalities need to be
NIAID Data Ecosystem20
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy
Although oncolytic adenoviruses have been widely studied for their direct oncolytic activity and immunomodulatory role in cancer immunotherapy, the immunosuppressive feedback loop induced by oncolytic
NIAID Data Ecosystem00
Immunodominant antiviral T cell responses outcompete immuno-subdominant antitumor responses to reduce the efficacy of oncolytic viroimmunotherapy
The paradigm in the field of oncolytic virotherapy proposes that tumor cell killing by an oncolytic virus (OV) culminates in the priming of antitumor CD8 T cells. However, this ignores the impact a hi
DataCite Commons2025-03-17 更新20
TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody induces tumor regression through profound tumor microenvironment remodeling and strong antitumor adaptive immune response [RNA-seq]. TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody induces tumor regression through profound tumor microenvironment remodeling and strong antitumor adaptive immune response [RNA-seq]
By their selective infection or replication into tumors, oncolytic viruses trigger profound modifications of tumor immune microenvironment with a massive infiltration and activation of T cells. This t
NIAID Data Ecosystem10
